Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-026369
Filing Date
2017-11-15
Accepted
2017-11-15 17:01:52
Documents
2
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4396
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4623
  Complete submission text file 0000899243-17-026369.txt   10605
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1345 AVENUE OF THE AMERICAS, 48TH FLOOR NEW YORK NY 10104
Business Address 1345 AVENUE OF THE AMERICAS, 48TH FLOOR NEW YORK NY 10104 212-698-3204
Anna-Maria & Stephen Kellen Foundation, Inc. (Reporting) CIK: 0001722602 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171205803